SK Hynix is preparing for its market debut on the Nasdaq in the United States [2].

The listing marks a significant expansion for the chipmaker as it seeks to capitalize on the surging demand for artificial intelligence infrastructure. The move allows the company to access U.S. capital markets while positioning itself closer to its primary technology partners.

Ben Reitzes, head of technology research at Melius Research, said he is very bullish on the memory sector. Speaking during an interview on CNBC’s ‘Squawk on the Street’ that aired June 23, 2026 [1], Reitzes said the company has strategic advantages in the current hardware cycle.

Reitzes pointed to SK Hynix’s leadership in high-bandwidth memory (HBM) and its established partnership with Nvidia as primary reasons for his optimistic outlook [5]. These technical advantages are critical as data centers require faster memory to process complex AI workloads.

The analyst said that the memory market is entering a strong growth phase. Strong growth is expected for the sector in the second half of 2026 [4]. This trajectory is supported by the increasing integration of AI across consumer, and enterprise software.

Looking further ahead, the industry expects a shift in supply dynamics. New production capacity is expected to come online in 2027 [4]. This expansion will be necessary to meet the projected long-term demand for high-performance memory chips.

SK Hynix, which trades under the ticker 000660.KS in other markets [3], is scheduled to make its U.S. debut on a Friday [3]. The listing is being compared by some analysts to other major technology initial public offerings due to the company's scale, and market influence.

“We're very bullish on memory”

The Nasdaq listing of SK Hynix signals a shift in the semiconductor landscape where memory is no longer a commodity but a strategic bottleneck for AI. By listing in the U.S., SK Hynix is aligning its financial structure with the ecosystem of AI giants like Nvidia, potentially stabilizing its valuation through direct exposure to American institutional investors during a period of high demand for HBM.